Audit Information	12 Months Ended
Audit Information	Sep. 30, 2025
Auditor [Table]
Auditor Name	Baker Tilly US, LLP
Auditor Firm ID	23
Auditor Location	Minneapolis, Minnesota
Auditor Opinion [Text Block]	Opinion on the Financial Statements We have audited the accompanying balance sheets of NeuroOne Medical Technologies Corporation (the “Company”) as of September 30, 2025 and 2024, the related statements of operations, changes in stockholders’ equity, and cash flows, for each of the two years in the period ended September 30, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2025 and 2024, and the results of the Company’s operations and cash flows for each of the two years in the period ended September 30, 2025, in conformity with accounting principles generally accepted in the United States of America.

NEUROONE MEDICAL TECHNOLOGIES Corp 10-K